Christine M. Lovly, MD, PhD is currently an associate professor of medicine with tenure at the Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center. She received a BA in chemistry from Johns Hopkins University followed by MD and PhD degrees as part of the Medical Scientist Training Program at Washington University in St. Louis, Missouri. She then completed internal medicine residency and medical oncology subspecialty training at Vanderbilt University. During her final year of fellowship, she was the Jim and Carol O’Hare Chief Fellow. She started on faculty at Vanderbilt in July 2013 as a physician scientist, splitting her time between clinical care and laboratory research. Her laboratory research is directed at understanding and developing improved therapeutic strategies for specific clinically relevant molecular subsets of lung cancer.
Dr. Lovly has received grant funding from NIH/NCI, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Sarcoma Foundation of America, the American Cancer Society, the Damon Runyon foundation, the LUNGevity foundation, the V Foundation, the American Association for Cancer Research, and Lung Cancer Foundation of America/International Association for the Study of Lung Cancer. She is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), and the American Association for Cancer Research (AACR). Dr. Lovly is also an elected member of the American Society for Clinical Investigation (ASCI) and a member of the Editorial Board for Cancer Discovery and JCO Precision Oncology. She serves on the Scientific Leadership Boards for the GO2 Foundation for Lung Cancer Research (where she also serves as SLB director), the LUNGevity Foundation, and the Lung Cancer Research Foundation. She is co-director of the AACR Molecular Biology in Clinical Oncology course and serves on the AACR Science Policy and Government Affairs committee. In 2021, she was awarded the ECOG-ACRIN Cancer Research Group Young Investigator Award.
Dr. Lovly has wanted to be a physician scientist since she was 16 and first worked in a research laboratory at Roswell Park Cancer Institute as part of a summer program for high school students. She feels fortunate to have been part of a community of inspiring mentors and teammates throughout her career, and she hopes to support, encourage, and elevate women in all aspects of science, technology, and medicine as they drive discovery and progress in cancer research.